Edoardo Bove's Journey to Redemption

Edoardo Bove sees the light at the end of the tunnel. The Roman midfielder, born in 2002, has not played since December 1, ...

Bove nears contract resolution with Roma, eyes move abroad

Roma and Edoardo Bove may soon part ways. The player is still contractually bound to the Giallorossi club, but since ...
pharmaphorum

FDA clears subcutaneous Keytruda in a boost to MSD

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
pharmaphorum

MSD says subcutaneous Keytruda matches IV form

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
Quotidiano Sportivo

Edoardo Bove, 13 months later, is ready to return to the field. He'll do so abroad, where he'll be eligible.

The Roman midfielder is negotiating a mutual termination with Roma. He will then sign as a free agent with a foreign club, ...